Literature DB >> 16428259

The optimal ratio of cases to controls for estimating the classification accuracy of a biomarker.

Holly Janes1, Margaret Pepe.   

Abstract

The case-control design is frequently used to study the discriminatory accuracy of a screening or diagnostic biomarker. Yet, the appropriate ratio in which to sample cases and controls has never been determined. It is common for researchers to sample equal numbers of cases and controls, a strategy that can be optimal for studies of association. However, considerations are quite different when the biomarker is to be used for classification. In this paper, we provide an expression for the optimal case-control ratio, when the accuracy of the biomarker is quantified by the receiver operating characteristic (ROC) curve. We show how it can be integrated with choosing the overall sample size to yield an efficient study design with specified power and type-I error. We also derive the optimal case-control ratios for estimating the area under the ROC curve and the area under part of the ROC curve. Our methods are applied to a study of a new marker for adenocarcinoma in patients with Barrett's esophagus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16428259     DOI: 10.1093/biostatistics/kxj018

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  7 in total

1.  Estimating the diagnostic likelihood ratio of a continuous marker.

Authors:  Wen Gu; Margaret Sullivan Pepe
Journal:  Biostatistics       Date:  2010-07-16       Impact factor: 5.899

2.  Statistical inference for net benefit measures in biomarker validation studies.

Authors:  Tracey L Marsh; Holly Janes; Margaret S Pepe
Journal:  Biometrics       Date:  2019-11-28       Impact factor: 2.571

3.  Bounding Sample Size Projections for the Area Under a ROC Curve.

Authors:  Jeffrey D Blume
Journal:  J Stat Plan Inference       Date:  2009-03-01       Impact factor: 1.111

4.  Optimal sampling ratios in comparative diagnostic trials.

Authors:  Ting Dong; Liansheng Larry Tang; William F Rosenberger
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2014-04       Impact factor: 1.864

5.  Diffuse cardiac fibrosis quantification in early systemic sclerosis by magnetic resonance imaging and correlation with skin fibrosis.

Authors:  Daniel C Lee; Monique E Hinchcliff; Roberto Sarnari; Madeline M Stark; Jungwha Lee; Kimberly Koloms; Aileen Hoffmann; Mary Carns; Anjali Thakrar; Kathleen Aren; John Varga; Alejandro Aquino; James C Carr; Brandon C Benefield; Sanjiv J Shah
Journal:  J Scleroderma Relat Disord       Date:  2018-04-12

6.  DNA methylation biomarkers offer improved diagnostic efficiency in lung cancer.

Authors:  Georgios Nikolaidis; Olaide Y Raji; Soultana Markopoulou; John R Gosney; Julie Bryan; Chris Warburton; Martin Walshaw; John Sheard; John K Field; Triantafillos Liloglou
Journal:  Cancer Res       Date:  2012-09-07       Impact factor: 12.701

7.  Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers.

Authors:  Johanna Jakobsdottir; Michael B Gorin; Yvette P Conley; Robert E Ferrell; Daniel E Weeks
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.